About The CJKHD
Canadian Journal of Kidney Health and Disease, the official journal of the Canadian Society of Nephrology, is an open access, peer-reviewed online journal that encourages high quality submissions focused on clinical, translational and health services delivery research in the field of chronic kidney disease, dialysis, kidney transplantation and organ donation.
Our mandate is to promote and advocate for kidney health as it impacts national and international communities.
CJKHD Equity, Diversity and Inclusivity (EDI) Principles
CJKHD recognizes that equitable, diverse and inclusive research environments are foundational to excellence, innovation and success within the Canadian and global research landscape. CJKHD is committed to ensuring that the principles of equity, diversity and inclusion are integrated into all of its activities, in an effort to drive deeper cultural change within the research ecosystem. CJKHD disseminates high-quality research and community-engaged scholarship globally, and strongly encourages submissions from a diverse range of authors from across all countries and backgrounds.
Equity, diversity and inclusion. CJKHD minimizes racism and gender bias by maintaining an editorial team and editorial board that includes a high proportion of women and men from various ethnicities. Our team is explicitly committed to respect, equity, diversity and inclusion in all our activities. Notably, the two editors-in-chief (founding and current) are both women. As the journal of the Canadian Society of Nephrology | Société canadienne de néphrologie we aim to reflect the multiple perspectives and inclusiveness of our national society. For feasibility and to aid dissemination, our publications and peer-review processes are conducted in English. Staff and editors at the journal will provide a French abstract for most publications. We explicitly strive for gender and geographic balance in the selection of associate editors, in the editorial board and among reviewers. We acknowledge the importance of relationships in all our work. We seek to treat all equally, all kindly, and all with the respect that they deserve.
The Canadian Journal of Kidney Health and Disease welcomes fundamental science and clinical science submissions in the field of kidney health from all people regardless of race, religion, ethnicity, gender, sexual orientation, nationality, or any other marker of social identity. We recognize our reparative responsibility to uplift the knowledges and expertise of Indigenous peoples in the field and welcome their submissions.
Catherine
Clase
Editor-In-Chief
Catherine Clase, MD, MSc, FRCPC
Editor-In-Chief
Dr. Clase completed degrees in pathology and in medicine at Christ’s College, Cambridge, UK, before moving to Canada for clinical training in internal medicine (Memorial University of Newfoundland), nephrology and health research methodology (McMaster University). Between 1997 and 2001 she was an assistant professor at Dalhousie University. She returned to McMaster University in 2001, where she is currently a professor of medicine in the Division of Nephrology, and an associate member of the Department of Health Research Methods, Evidence and Impact. Research interests include the population epidemiology of chronic kidney disease (CKD), optimization of medical management in CKD, and the prevention of thrombotic and bleeding complications in people with CKD. In 2019 she co-chaired the Canadian commentary on KDIGO metabolic bone disease guidelines and co-chaired the KDIGO potassium controversies conference. She is the medical lead of the St Joseph’s Hamilton Healthcare program for transitioning young people with kidney disease from pediatric to adult practice. In the pandemic, she co-led a review of the filtration properties of cloth masks, co-created the plain language website www.clothmasks.org, and works as faculty within the newly-formed Centre of Excellence in Protective Equipment and Materials at McMaster University to improve and promote masks for community use.
Sunny
Hartwig
Managing Editor
Sunny Hartwig, MSc, PhD
Managing Editor
Dr. Sunny Hartwig is an associate professor in the Department of Biomedical Sciences, Atlantic Veterinary College, University of Prince Edward Island, a CIHR university delegate, and Member of the College, Royal Society of Canada. She obtained her PhD. in renal developmental biology at the Hospital for Sick Children, University of Toronto, and completed a post-doctoral fellowship in developmental nephrology at Boston Children’s Hospital, Harvard Medical School. Dr. Hartwig’s research is focused on the molecular regulation of nephrogenesis by members of the Sry-related HMG box (SOX) family of transcription factors, and her work is supported by the Kidney Foundation and CIHR.
Josée
Bouchard
Deputy Editor
Josée Bouchard, MD, FRCPC
Deputy Editor
Dr. Bouchard is a clinician researcher and nephrologist at the Hôpital du Sacré-Cœur de Montréal, and a professor of medicine at the Université de Montreal. She completed her training in Montreal and at the University of California San Diego. Her main research interests are acute kidney injury and toxicology. She has published over 90 peer-reviewed papers and several book chapters in the field.
Rachel
Holden
Deputy Editor
Rachel M. Holden, MD, FRCPC
Deputy Editor
Dr. Holden is a nephrologist and a professor in the Department of Medicine with a cross-appointment to the Department of Biomedical and Molecular Sciences at Queen's University. She joined the faculty in 2001.
She currently holds a Clinician Scientist award. Dr. Holden and her associates study basic mechanisms of vascular calcification in chronic kidney disease. A focus of her research program is clinical, basic and translational aspects of vitamin K metabolism and specifically the role of vitamin K in the inhibition of vascular calcification.
Dr. Holden's clinical interests include mineral bone disorders in chronic kidney disease and hemodialysis patients
Karthik
Tennankore
Deputy Editor
Karthik Tennankore, MD, MSc, FRCPC
Deputy Editor
Dr. Tennankore is a nephrologist and associate professor in the Department of Medicine at Dalhousie University, and QEII Foundation endowed chair in Transplantation Research at the QEII Health Sciences Centre. Dr. Tennankore completed his medical degree at the University of Western Ontario, his internal medicine residency and nephrology fellowship at Dalhousie University, and a Master of Science in Clinical Epidemiology at Harvard University.
Dr. Tennankore is interested in studying and improving outcomes of patients after initiation of dialysis and transplantation, and he is a part of national and international research initiatives in home hemodialysis. He is involved in clinical trials and conducts a number of prospective cohort studies in nephrology.